
TY-2136 is a next generation ROS1/TRK/ALK ингибитор с IC50 of 1.6 nM and 460.1 nM for ROS1 G2032R and TRKA G595R, respectively, inhibits ROS1/TRK/ALK mutations and overcomes препарат resistance due to acquired solvent-front mutations.
TY-2136 is a next generation ROS1/TRK/ALK inhibitor with IC50 of 1.6 nM and 460.1 nM for ROS1 G2032R and TRKA G595R, respectively, inhibits ROS1/TRK/ALK mutations and overcomes drug resistance due to acquired solvent-front mutations.
Только для научно-исследовательского применения. Не предназначено для использования у пациентов или в качестве лекарственного средства.